What we do
We empower life sciences to collect high quality imaging data and harness the power of AI to accelerate drug development/approval.
Optimized Imaging for Clinical Trials
VIDA’s platform-enabled services enable exceptional imaging data quality & highly efficient site operations.
Robust Imaging Data for Therapeutic Research
Utilize AI-powered insights and rich data repositories to examine cohorts, better understand disease, & discover new biomarkers.
Data-Driven Clinical Development Planning
Use clinical and operational data to inform biomarker & site selection, in addition to novel services like external control arms & digital twins.
Clinical Trial Imaging
Leverage data to enhance patient targeting and improve trial outcomes, driving more efficient and effective studies.
Strategic Planning
Use data to inform long-term strategic decisions, supporting investment in cutting-edge AI and maximizing value from imaging data.
Therapeutic Research
Utilize AI-powered insights to accelerate therapeutic innovation, optimizing drug development and discovery.
Our Experience
Our Leadership Team
Susan Wood, PhD 
CEO
Dr. Wood has 25+ years of experience championing innovative clinical solutions to the marketplace, from concept to revenue. Dr. Wood received her Ph.D. from the Johns Hopkins Medical Institutions, School of Hygiene and Public Health. Her Ph.D. work combined quantifying three-dimensional lung structure with changes in lung function using high-resolution CT imaging. She also holds a Master of Science degree in Biomedical Engineering from Duke University, and a Bachelor of Science in Engineering from the University of Maryland, College Park.
John Newell, MD, PhD, FACR
Medical Director
Dr. John Newell Jr, MD, is a professor of Radiology and Biomedical Engineering, Director of the Radiology Image Phenotyping Laboratory, and co-Director of the Iowa Institute for Biomedical Imaging. He has over 30 years of experience in clinical research and clinical practice in the Radiology sub-specialty of Cardio-Thoracic Radiology. John’s book, Developing the Digital Lung, chronicles major advances in quantitative lung imaging.
Michael Blaha
VP, Engineering & Development
Mr. Blaha brings over 25 years of experience in computer technology, with a background spanning startups to Fortune 5 companies and encompassing e-commerce, healthcare payers, medical documentation, and medical imaging.
Throughout his career, he has led teams in delivering innovative solutions, including SaaS-based platforms, cloud-native architectures, big data systems, AI security and analysis tools, and high-performance imaging viewers.
Michael is passionate about solving complex problems and creating impactful, industry-disrupting capabilities that drive progress at the exciting intersection of medicine and technology.
Ryan Howell
VP, FP&A
Mr. Howell has over 25 years of experience in various finance and accounting leadership roles including extensive experience within the SaaS (Software as a Service) industry and healthcare space. He received BA degrees in accounting and business management from Central College, earned his MBA in Finance from the University of Iowa, and is an inactive CPA.
Marcel Nienhuis
Vice President of Marketing
Mr. Nienhuis has over 25 years’ experience in marketing, product management, strategy, business development and market research. Marcel holds an MBA from the Carlson School of Management at the University of Minnesota and a Bachelor of Science in Commerce, Marketing from Santa Clara University.
Industry Recognition
We are honored to have received the following recognition in recent years.
2023
Outstanding Leadership Award
Outstanding Leadership Award
2023
Fastest Growing Private Company List
2023
Ecovadis Silver Medal
in Sustainability
2020
Frost & Sullivan AI Lung Company of the Year
2020
15 Companies that are Saving the World from COVID-19
2020
Top 50 Healthcare Tech CEO
Major Investors
+1.855.700.8432 (VIDA)